» Articles » PMID: 21955466

Lack of Adaptation to Human Tetherin in HIV-1 Group O and P

Overview
Journal Retrovirology
Publisher Biomed Central
Specialty Microbiology
Date 2011 Sep 30
PMID 21955466
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HIV-1 viruses are categorized into four distinct groups: M, N, O and P. Despite the same genomic organization, only the group M viruses are responsible for the world-wide pandemic of AIDS, suggesting better adaptation to human hosts. Previously, it has been reported that the group M Vpu protein is capable of both down-modulating CD4 and counteracting BST-2/tetherin restriction, while the group O Vpu cannot antagonize tetherin. This led us to investigate if group O, and the related group P viruses, possess functional anti-tetherin activities in Vpu or another viral protein, and to further map the residues required for group M Vpu to counteract human tetherin.

Results: We found a lack of activity against human tetherin for both the Vpu and Nef proteins from group O and P viruses. Furthermore, we found no evidence of anti-human tetherin activity in a fully infectious group O proviral clone, ruling out the possibility of an alternative anti-tetherin factor in this virus. Interestingly, an activity against primate tetherins was retained in the Nef proteins from both a group O and a group P virus. By making chimeras between a functional group M and non-functional group O Vpu protein, we were able to map the first 18 amino acids of group M Vpu as playing an essential role in the ability of the protein to antagonize human tetherin. We further demonstrated the importance of residue alanine-18 for the group M Vpu activity. This residue lies on a diagonal face of conserved alanines in the TM domain of the protein, and is necessary for specific Vpu-tetherin interactions.

Conclusions: The absence of human specific anti-tetherin activities in HIV-1 group O and P suggests a failure of these viruses to adapt to human hosts, which may have limited their spread.

Citing Articles

Complex Relationships between HIV-1 Integrase and Its Cellular Partners.

Rozina A, Anisenko A, Kikhai T, Silkina M, Gottikh M Int J Mol Sci. 2022; 23(20).

PMID: 36293197 PMC: 9603942. DOI: 10.3390/ijms232012341.


Site-Specific Evolutionary Rate Shifts in HIV-1 and SIV.

Gelbart M, Stern A Viruses. 2020; 12(11).

PMID: 33207801 PMC: 7696578. DOI: 10.3390/v12111312.


Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Heusinger E, Deppe K, Sette P, Krapp C, Kmiec D, Kluge S J Virol. 2018; 92(18).

PMID: 29976668 PMC: 6146695. DOI: 10.1128/JVI.00276-18.


Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.

Foster T, Pickering S, Neil S Front Immunol. 2018; 8:1853.

PMID: 29354117 PMC: 5758531. DOI: 10.3389/fimmu.2017.01853.


Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Sato K, Misawa N, Takeuchi J, Kobayashi T, Izumi T, Aso H J Virol. 2017; 92(4).

PMID: 29212937 PMC: 5790958. DOI: 10.1128/JVI.01905-17.


References
1.
Schubert U, Anton L, Bacik I, Cox J, Bour S, Bennink J . CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol. 1998; 72(3):2280-8. PMC: 109526. DOI: 10.1128/JVI.72.3.2280-2288.1998. View

2.
Yamaguchi J, Vallari A, Swanson P, Bodelle P, Kaptue L, Ngansop C . Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters. AIDS Res Hum Retroviruses. 2002; 18(4):269-82. DOI: 10.1089/088922202753472847. View

3.
Gao F, Bailes E, Robertson D, Chen Y, Rodenburg C, Michael S . Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 1999; 397(6718):436-41. DOI: 10.1038/17130. View

4.
Skasko M, Tokarev A, Chen C, Fischer W, Pillai S, Guatelli J . BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology. 2011; 411(1):65-77. PMC: 3086044. DOI: 10.1016/j.virol.2010.12.038. View

5.
Ayouba A, Mauclere P, Martin P, Cunin P, Mfoupouendoun J, Njinku B . HIV-1 group O infection in Cameroon, 1986 to 1998. Emerg Infect Dis. 2001; 7(3):466-7. PMC: 2631804. DOI: 10.3201/eid0703.010321. View